A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab

Identifying Patients at High Risk of Loss of Response to Infliximab Maintenance Therapy in Paediatric Crohn’s Disease

(2016) Claire Dupont-Lucas et al.   Journal of Crohns & Colitis

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease

(2016) Haruhiko Ogata et al.   Journal of Crohns & Colitis

Anti-TNF Monotherapy for Crohn’s Disease: a 13-year Multicentre Experience

(2016) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease

(2015) Taha Qazi et al.   DIGESTIVE DISEASES AND SCIENCES

Azathioprine discontinuation earlier than 6 months in Crohn’s disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation

(2015) Nikos Viazis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center

(2015) Klaudia Farkas et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn’s disease

(2015) Sarah O’Donnell et al.   Journal of Crohns & Colitis

NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD

(2015) Y Kakuta et al.   PHARMACOGENOMICS JOURNAL

Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

(2014) C. Ma et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

(2014) Mamoru Watanabe et al.   Journal of Crohns & Colitis

Therapy of Steroid-Resistant Inflammatory Bowel Disease

(2012) Michael Manz et al.   DIGESTION

Response to biologic therapy in Crohnʼs disease is improved with early treatment: An analysis of health claims data

(2012) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan

(2012) Fumiaki Ueno et al.   JOURNAL OF GASTROENTEROLOGY

Review article: loss of response to anti-TNF treatments in Crohn’s disease

(2011) S. Ben-Horin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease

(2011) Mamoru Watanabe et al.   Journal of Crohns & Colitis

Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan

(2010) Takashi Ishige et al.   JOURNAL OF GASTROENTEROLOGY

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn’s Disease

(2009) Joel R Rosh et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Durability of infliximab in Crohnʼs disease

(2009) Jason E. Gonzaga et al.   INFLAMMATORY BOWEL DISEASES

Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease

(2009) Noritaka Takatsu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients

(2008) A. SWAMINATH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients

(2008) Takako Komiyama et al.   Journal of Crohns & Colitis

Infliximab dependency in pediatric Crohnʼs disease: Long-term follow-up of an unselected cohort

(2007) Lissy de Ridder et al.   INFLAMMATORY BOWEL DISEASES